V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330008197 | 330004991 | 0 | 29 | Palliative (P) | 2017-08-11 | 2017-08-11 | Cisplatin + Etoposide po&iv 3 day | N | null | 330015638 | CAV |
| 330008198 | 330004993 | 1.5 | 64.6 | Palliative (P) | 2015-09-24 | 2015-10-01 | EURO-EWING | N | null | 330015651 | EURO-EWING |
| 330008199 | 330004994 | 1.69 | null | Palliative (P) | 2014-10-08 | 2014-10-21 | VAC | N | N | 330015657 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008200 | 330004994 | 1.65 | 55.5 | Curative (C) | 2015-05-15 | 2015-10-02 | Trabectedin | 02 | N | 330015657 | TRABECTEDIN |
| 330008201 | 330004995 | 1.57 | 28.6 | Palliative (P) | null | 2017-10-10 | Vinblastine | N | N | 330015668 | AZACITIDINE |
| 330008202 | 330004996 | 1.6 | 57.8 | Palliative (P) | 2018-04-07 | 2018-04-19 | ETOPOSIDE | N | N | 330015668 | ETOPOSIDE |
| 330008203 | 330004997 | null | 37.4 | Curative (C) | 2017-02-19 | 2017-02-23 | Irinotecan + Temozolomide | N | N | 330015679 | IRINOTECAN + TEMOZOLOMIDE |
| 330008204 | 330004998 | 1.78 | 75 | Palliative (P) | 2017-02-11 | 2017-02-11 | Cyclophosphamide + Dex + Rituximab | N | N | 330015679 | NIVOLUMAB |
| 330008205 | 330004999 | 1.58 | 55.4 | Disease modification (D) | 2016-08-16 | 2016-08-16 | Methotrexate intrathecal | 2 | null | 330015708 | METHOTREXATE INTRATHECAL |
| 330008206 | 330004999 | null | 60 | Curative (C) | 2014-03-14 | 2014-03-21 | TEMOZOLOMIDE | N | null | 330015708 | DA |
| 330008207 | 330008730 | 1.7 | 78.7 | Adjuvant (A) | 2013-10-16 | 2013-10-19 | Cytarabine High Dose | N | N | 330015750 | CYTARABINE HIGH DOSE |
| 330008208 | 330005001 | 1.75 | null | Palliative (P) | 2016-11-14 | 2016-11-25 | CISPLATIN + ETOPOSIDE | null | null | 330015754 | VINBLASTINE |
| 330008209 | 330005001 | 1.53 | 59.4 | Adjuvant (A) | 2015-02-04 | 2015-08-04 | IRINOTECAN + TEMOZOLOMIDE | 2 | N | 330015754 | IRINOTECAN + TEMOZOLOMIDE |
| 330008210 | 330005003 | 1.8 | 91.8 | null | 2017-01-03 | 2017-01-09 | Docetaxel | 2 | N | 330015770 | DOCETAXEL |
| 330008211 | 330005003 | 1.72 | null | Palliative (P) | 2017-01-24 | 2017-05-09 | Temozolomide 200mg/m2 | N | N | 330015770 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330008212 | 330010735 | 1.58 | 52.1 | Neo-adjuvant (N) | 2013-05-28 | 2013-06-26 | Cyclophosphamide + Dex + Rituximab | 2 | N | 330015800 | CAV |
| 330008213 | 330012481 | 0 | 54.2 | Palliative (P) | 2015-08-07 | 2016-01-01 | Liposomal Doxorubicin (Caelyx) | N | N | 330015829 | LIPOSOMAL DOXORUBICIN |
| 330008214 | 330012481 | 1.66 | 56.3 | Adjuvant (A) | 2017-01-17 | 2017-01-17 | GemCarbo Days 1+8 | 2 | Y | 330015829 | GEMCARBO |
| 330008215 | 330012481 | 0 | 90.2 | Palliative (P) | 2015-09-18 | 2015-12-22 | GEMCARBO | N | N | 330015829 | GEMCARBO |
| 330008216 | 330005004 | 1.57 | 42 | Curative (C) | 2014-05-18 | 2015-03-02 | Cytarabine High Dose | N | N | 330015848 | CYTARABINE HIGH DOSE |
| 330008217 | 330005006 | 1.7 | 63.2 | Neo-adjuvant (N) | 2016-04-30 | 2016-08-12 | Azacitidine | N | N | 330015859 | CAV |
| 330008218 | 330005006 | 1.75 | 76.75 | Palliative (P) | 2015-08-19 | 2015-08-21 | NIVOLUMAB | N | N | 330015859 | NIVOLUMAB |
| 330008219 | 330010737 | 1.78 | 90 | Palliative (P) | 2015-10-30 | 2015-11-19 | NIVOLUMAB | N | N | 330015869 | TEMOZOLOMIDE |
| 330008220 | 330010737 | 1.68 | 85.5 | Palliative (P) | 2017-01-14 | 2017-01-14 | Liposomal Doxorubicin (20mg/m2) | 02 | null | 330015869 | LIPOSOMAL DOXORUBICIN |
| 330008221 | 330010737 | 0 | 13.4 | Palliative (P) | 2018-10-17 | 2018-12-03 | EURO-EWING | N | N | 330015869 | EURO-EWING |
| 330008222 | 330005007 | null | 63.5 | Palliative (P) | 2014-09-01 | 2014-09-02 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330015905 | TEMOZOLOMIDE |
| 330008223 | 330008736 | 1.6 | 79.2 | Palliative (P) | 2015-10-09 | 2015-10-17 | EW EuroEwing 99 : VIDE | 2 | N | 330015910 | EURO-EWING |
| 330008224 | 330005008 | 1.59 | 29.9 | Palliative (P) | null | 2015-11-03 | ETOPOSIDE | null | null | 330015926 | ETOPOSIDE |
| 330008225 | 330005009 | 1.62 | 46.8 | Curative (C) | 2013-03-18 | 2013-03-25 | Methotrexate intrathecal | N | N | 330015927 | METHOTREXATE INTRATHECAL |
| 330008226 | 330010739 | 1.6 | 74.65 | Adjuvant (A) | 2013-09-19 | 2013-10-09 | DA 3+8 | N | N | 330015927 | CISPLATIN + DOXORUBICIN |
| 330008227 | 330005012 | 1.67 | 113 | Disease modification (D) | 2015-08-27 | 2015-11-21 | ETOPOSIDE | null | null | 330015949 | ETOPOSIDE |
| 330008228 | 330005012 | 1.81 | 63.5 | Palliative (P) | 2017-07-30 | 2017-07-30 | TEMOZOLOMIDE | N | N | 330015949 | VINBLASTINE |
| 330008229 | 330005014 | 1.57 | 61 | null | 2014-05-12 | 2014-05-22 | Cyclophosphamide + Topotecan | N | N | 330015969 | TEMOZOLOMIDE |
| 330008230 | 330005016 | 1.87 | 64 | Curative (C) | 2011-09-02 | 2013-09-30 | EURO-EWING | 02 | N | 330015971 | EURO-EWING |
| 330008231 | 330005019 | 1.7 | 92.1 | Palliative (P) | 2013-03-23 | 2013-04-26 | EURO-EWING | N | N | 330015996 | EURO-EWING |
| 330008232 | 330005024 | 1.53 | 54.2 | Palliative (P) | 2013-08-25 | 2013-08-25 | Cisplatin + Doxorubicin | Y | N | 330016000 | TEMOZOLOMIDE |
| 330008233 | 330005024 | 1.55 | 59.4 | Not known (9) | 2016-10-22 | 2016-10-29 | Cisplatin + Doxorubicin | N | null | 330016000 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330008234 | 330005024 | 1.7 | 35.1 | Palliative (P) | null | 2016-01-29 | FLAG + Idarubicin | null | null | 330016000 | FLAG + IDARUBICIN |
| 330008235 | 330005024 | 1.64 | 68.3 | null | 2016-04-11 | 2016-04-11 | Azacitidine | N | null | 330016000 | CISPLATIN + DOXORUBICIN |
| 330008236 | 330005025 | 1.63 | 23.7 | Curative (C) | 2015-04-22 | 2015-07-18 | DA 3+8 | N | N | 330016037 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330008237 | 330005026 | 1.63 | 74.4 | Palliative (P) | null | 2014-03-25 | Cisplatin + Doxorubicin | 02 | null | 330016047 | NIVOLUMAB |
| 330008238 | 330005027 | 1.69 | 43.6 | Palliative (P) | 2013-01-15 | 2013-06-18 | EW EuroEwing 2012 Arm A VIDE | N | N | 330016047 | EURO-EWING |
| 330008239 | 330005031 | 1.64 | 46 | null | 2016-12-21 | 2016-12-21 | DA 3 + 10 | 02 | N | 330016050 | CISPLATIN + ETOPOSIDE |
| 330008240 | 330005032 | null | 100.3 | Neo-adjuvant (N) | 2017-10-24 | 2017-11-04 | DA 3+8 | N | N | 330016051 | CISPLATIN + DOXORUBICIN |
| 330008241 | 330005032 | 1.63 | 69.1 | Palliative (P) | null | 2013-12-04 | Liposomal Doxorubicin (Caelyx) | null | Y | 330016051 | LIPOSOMAL DOXORUBICIN |
| 330008242 | 330005033 | 0 | 82 | Curative (C) | 2013-10-10 | 2014-02-01 | Methotrexate intrathecal | 02 | N | 330016088 | METHOTREXATE INTRATHECAL |
| 330008243 | 330005034 | 1.78 | 79 | null | 2014-07-15 | 2014-07-15 | CARBOPLATIN + GEMCITABINE | 02 | N | 330016114 | GEMCARBO |
| 330008244 | 330008752 | 1.64 | null | null | 2014-06-14 | 2014-07-04 | GemCarbo Days 1+8 | N | null | 330016125 | GEMCARBO |
| 330008245 | 330010741 | 1.55 | 36.8 | Palliative (P) | 2015-07-12 | 2015-07-12 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 330016125 | EURO-EWING |
| 330008246 | 330005035 | 1.78 | 89.7 | Disease modification (D) | 2014-12-18 | 2015-01-16 | Liposomal Doxorubicin (Caelyx) | N | Y | 330016135 | LIPOSOMAL DOXORUBICIN |